Clinical Trials Browser

Phase 2 × NETWORK × peginterferon alfa-2b × Clear all

NCT00049530 2023-06-29

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma

Phase 2 Completed

32 enrolled 8 charts

Melanoma